Evening Washington
Wednesday, April 21, 2021
  • Africa
  • Asia
  • Europe
  • latest news
  • USA News
  • World
  • Other
    • TECH
    • Health
    • Fashion
    • Sports
    • Business
No Result
View All Result
  • Africa
  • Asia
  • Europe
  • latest news
  • USA News
  • World
  • Other
    • TECH
    • Health
    • Fashion
    • Sports
    • Business
No Result
View All Result
Evening Washington
No Result
View All Result
Home Health

FDA Approves ‘Biosimilar’ Drug Ogivri for Breast, Stomach Cancers

admin by admin
December 1, 2017
in Health
0
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

RELATED POSTS

Covid-19: White House criticises ‘chaotic’ vaccine rollout

Type 2 diabetes: Mindfulness shown to lower high blood sugar levels – how to practice it

FRIDAY, Dec. 1, 2017 (HealthDay News) — Ogivri (trastuzumab-dkst) has been approved by the U.S. Food and Drug Administration as the nation's first biosimilar drug to treat certain breast and stomach cancers, the agency said Friday in a news release.

The maker of a biosimilar, derived from a living organism, must demonstrate that the new product is "highly similar" to an already approved medication, and that it has no clinically significant difference in terms of its potency, safety and purity, the FDA said.

Ogivri is approved to treat breast or stomach cancers attributed to a problematic HER2+ gene. The FDA said its maker, Mylan, provided sufficient evidence that the drug is biosimilar to the Genentech drug Herceptin, which was approved by the agency in 1998.

"The FDA continues to grow the number of biosimilar approvals, helping to promote competition that can lower health care costs," said FDA Commissioner Dr. Scott Gottlieb. "This is especially important when it comes to a disease like cancer, that has a high cost burden for patients."

Expected side effects for Ogivri include headache, diarrhea, nausea, chills, fever, infection, congestive heart failure, insomnia, cough and rash, the FDA said.

Like Herceptin, Ogivri's label will include a boxed warning about an increased risk of heart disease, serious allergic-like reactions, lung damage and harm to a developing fetus, the agency said.

Mylan is based in Canonsburg, Penn.

More information

The FDA has more about this approval.

Original Article

Health

ShareTweetPin
admin

admin

Related Posts

Covid-19: White House criticises ‘chaotic’ vaccine rollout

Covid-19: White House criticises ‘chaotic’ vaccine rollout

by admin
January 24, 2021
0

A senior White House official has criticised the Trump administration's rollout of the Covid-19 vaccine calling it "chaotic" and "very...

Type 2 diabetes: Mindfulness shown to lower high blood sugar levels – how to practice it

Type 2 diabetes: Mindfulness shown to lower high blood sugar levels – how to practice it

by admin
November 24, 2020
0

Type 2 diabetes is characterised by a battle with high blood sugar levels, which can inflict serious damage on the body. High...

Prince George’s Approves Requiring Healthy Kids’ Meals at Restaurants

Prince George’s Approves Requiring Healthy Kids’ Meals at Restaurants

by admin
November 19, 2020
0

A healthy meal and drink will soon be the required default option for kids’ meals at all restaurants in Prince...

Asian Games: Two Indonesian skateboarders secure ticket to final

by webadmin
October 11, 2020
0

When we get out of the glass bottle of our ego and when we escape like the squirrels in the...

Burkina Faso: Growing Violence Threatens Health Care

Burkina Faso: Growing Violence Threatens Health Care

by admin
September 10, 2019
0

Away from the worlds attention, Burkina Faso has been slipping into violence. In less than a year, t..

Next Post
Lung Cancer Drug Targets ‘Hidden’ HIV in French Patient

Lung Cancer Drug Targets 'Hidden' HIV in French Patient

Welsh and Scottish health ministers call for folic acid in flour

Welsh and Scottish health ministers call for folic acid in flour

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Sport

Winners and losers from men’s NCAA Tournament second-round games

Winners and losers from men’s NCAA Tournament second-round games

March 23, 2021
Mets retaining Luis Rojas as manager

Mets retaining Luis Rojas as manager

November 24, 2020
  • 22.1M Fans
  • 85 Followers
  • 113k Subscribers
  • 657 Followers
  • 23k Followers

MOST VIEWED

  • ‘Amphan’ may bring first flood of year in Assam: CWC

    ‘Amphan’ may bring first flood of year in Assam: CWC

    0 shares
    Share 0 Tweet 0
  • Playboy Model Marisa Papen Arrested For Dragging Cross In Front Of Vatican While Naked

    0 shares
    Share 0 Tweet 0
  • Russia Scores Gold In Women’s Figure Skating, Leaving USA Ladies Without Medals

    0 shares
    Share 0 Tweet 0
  • 11 Effortless Ways to Wear Adidas Pants Like a Street Style Pro

    0 shares
    Share 0 Tweet 0
  • Where to buy Bitcoin in the UK and how does it work

    0 shares
    Share 0 Tweet 0

CATEGORY

  • Africa
  • Asia
  • Business
  • Europe
  • Fashion
  • Health
  • latest news
  • Sports
  • TECH
  • Uncategorized
  • USA News
  • World

SITE LINKS

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
  • Landing Page
  • All Features
  • Get JNews
  • Contact

© 2020 eveningwashington.com.

No Result
View All Result
  • Africa
  • Asia
  • Europe
  • latest news
  • USA News
  • World
  • Other
    • TECH
    • Health
    • Fashion
    • Sports
    • Business

© 2020 eveningwashington.com.